XOLTAR

In honor of International #Breast #Cancer Awareness Month, we at XOLTAR are proud to reaffirm our commitment to advancing cancer care through our AI-driven solutions. Cancer support is a core part of XOLTAR’s strategy, and we're constantly working to develop innovative tools that help patients feel empowered, connected, and supported throughout their journey. This month is an important reminder of the progress being made and the work we continue to do. We're excited to share some of the impactful initiatives underway. Our ongoing collaboration with Beilinson-Samueli Medical Center and Novartis is a prime example: together, we're developing a specialized AI skill for breast cancer support, with plans for a collaborative research study launching next year. Earlier this year, we also completed research focused on supporting ovarian cancer patients at Wolfson Medical Center . This study allowed us to gain deeper insights into the unique emotional and physical challenges faced by cancer patients, helping to guide the development of future solutions. To highlight our progress, we’ve just released a new demo video that showcases the personalized support XOLTAR can offer to patients in #oncology. We invite you to take a look and learn more about our approach. We'd be delighted to connect, discuss our technology, and share how XOLTAR is leading the way in generative AI-based cancer care. Let's work together to make the journey for cancer patients less isolating, more supportive, and filled with hope. Heartfelt thanks to Yael Feldman Shavit for your incredible direction and production of the video! Tally Levy Ori Tal Ornit Cohen Novartis Israel Tal Vardi Maya Balan Noa Matzner Malachy Shalhevet Felsenstein Rinat Yerushalmi Gal Markel Avner Paz-Tsuk Matan Ben-Zion Berliner Silvi Daniel Tal Saada The Samueli Integrative Cancer Pioneering Institute

Excitement is in the air at #HLTH2024! We're proud to be part of the Israeli Pavilion, where our innovative AI solution is creating quite a buzz! The responses to our multilingual demo in English, Spanish, and Japanese are truly heartwarming. It's incredible to see healthcare leaders, providers, and industry innovators gathering at our booth to explore how our AI-powered solution can support their patients through their journey, and improve medical solutions. We're especially grateful for all the meaningful connections we're making and the potential partnerships brewing. Come visit us at Booth #2254 (Israeli Pavilion, Kiosk #2) to experience our demo in your preferred language. The future of healthcare is multilingual, and we're here to lead the way! Israel Export Institute מכון היצוא Israel Economic Mission to the West Coast  Israel Economic Mission to the USA - East Coast

With less than a week to go until #HLTH24 in Las Vegas, we invite you to visit the XOLTAR kiosk (#2) in the Israel delegation booth (#2254) to meet Asaf Shiloni, Adi Y. Segal, and Yizhar Feldman. This is a fantastic opportunity to experience our demo firsthand, also available in #Spanish and #Japanese this time! ¡Menos de una semana para lansamiento del HLTH24 en Las Vegas! Conozcan a Asaf, Adi y Yizhar en el stand 2254 (Quiosco 2) de la delegación israelí. Es una excelente oportunidad para experimentar nuestra demostración, ¡y ahora esta disponible en los idiomas español y japonés! 「ラスベガスでのHLTH24まであと1週間を切りました！イスラエル代表団のブース2254（キオスク2）でAsaf、Adi、Yizharにお会いしましょう。私たちのデモを体験する絶好の機会です。 今回はスペイン語と日本語でもご利用いただけますので、お気軽にお越しください！」 Israel Export Institute מכון היצוא HLTH Inc. HLTH Foundation https://lnkd.in/di9kEjZK

We’re excited to announce that we’ll be attending #HLTH 2024 this year! If you’re planning to be there and want to connect, we’d love to meet. Feel free to reach out to Adi Y. Segal, Asaf Shiloni, or Yizhar Feldman to schedule a meeting, or you can use the following Calendly link: https://lnkd.in/di9kEjZK Looking forward to productive discussions and new opportunities! #HealthcareInnovation #DigitalHealth #PharmaTech #FutureOfHealthcare

Exciting news! XOLTAR is revolutionizing cancer patient care with our latest AI-powered program for breast cancer patients. The program will provide 24/7 personalized guidance, monitoring for enhanced treatment, and emotional support. This breakthrough represents a major step in transforming oncology care through technology. We're thrilled about its potential impact and future expansion to other cancer areas. Proud of our team's hard work! Stay tuned for more as we continue pushing the boundaries of AI in healthcare. #Innovation #AIinHealthcare #BreastCancerResearch #PinkOctober https://lnkd.in/dtei_6Gt

Thrilled to welcome Adi Y. Segal as XOLTAR's Executive Advisor for Partnerships & Growth! Adi brings a wealth of experience in scaling startups, optimizing customer operations, and driving business development in digital and behavioral health. His leadership in high-growth ventures like Hapi and Genoa Telepsychiatry, along with his strategic partnerships with top insurance and pharma companies, aligns seamlessly with our vision. With over a decade of advising numerous health tech companies and leading successful VC-backed exits, Adi’s innovative approach, deep understanding of regulated industries, and passion for increasing access to care make him a powerful addition to the team. His unique blend of clinical and digital expertise will be invaluable as we continue to revolutionize healthcare through AI and transformative technology. Welcome aboard, Adi! #Teamgrowth #Welcome #growth

Seeing our #Ovarian #Cancer product featured at a prestigious medical conference is such a huge and humbling #milestone! Prof. Tally Levy and Dr. Ori Tal from the Gyneco-oncologic department at Wolfson Medical Center 's results of our collaborative study were accepted to the International Gynecologic Cancer Society (#IGCS) conference in Dublin, Ireland, from October 16-18, 2024 (#IGCS2024) The study is based on the initial phase of our collaboration, which encompasses long-lasting patient relationships aggregated over hours of human-machine interactions. Results show the human likeness of our AI accountability partners and how it leads to patient engagement and monitoring of PROs. This is a unique and exciting opportunity to showcase our innovative platform for patient care on a global stage. Stay tuned for more updates!#HealthcareInnovation #AI #PatientEngagement #PROs #Retention #IGCS2024 #CancerCare

Honored to present XOLTAR's AI-powered patient relationship solutions and their validated outcomes at the Novartis Israel Healthcare Innovation Meetup! Thank you, Elad Maron, Tal Vardi, and the Novartis Israel team, for the opportunity to showcase our various collaborations and products to this group of influencers and decision-makers, and more than that, for being so much more than a client and design partner in paving XOLTAR's path to becoming the global platform for #PatientRelationship. Stay tuned for grand new collaborations to come! #HealthcareInnovation #AI #CancerCare #FutureOfOncology #AICompaions

Both Google and OpenAI published their spring updates, with many new interesting features. Read what Alex Gendelman, our head of #AI thinks about it in XOLTAR 's A Call for Action blog: https://lnkd.in/dNQFCG8R

Thank you Gerson Panitch for spotlighting XOLTAR at the fabulous HealthIL event! We look forward to seeing who's next in your #whatsnextinisraeltech series 😉. Wonderful project you have there 💪 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP #healthweek #AIHealthcare #patientsupport